Literature DB >> 13539378

Studies of the inactivation of phage by the properdin system. I. Evidence for complement, properdin and magnesium requirements.

J L BARLOW, H VAN VUNAKIS, L LEVINE.   

Abstract

Entities:  

Keywords:  BACTERIOPHAGE; COMPLEMENT; MAGNESIUM/metabolism; PROPERDIN

Mesh:

Substances:

Year:  1958        PMID: 13539378

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  9 in total

1.  Development of bactericidal properties against gram-negative organisms in the serum of young animals.

Authors:  J STERZL; J KOSTKA; A LANC
Journal:  Folia Microbiol (Praha)       Date:  1962-05       Impact factor: 2.099

2.  [The properdin problem].

Authors:  H E SCHULTZE; G SCHWICK
Journal:  Blut       Date:  1958-11

3.  Interference by endotoxic polysaccharides with inactivation of coliphage by human serum.

Authors:  M LANDY; R J TRAPANI; M J SHEAR
Journal:  Br J Exp Pathol       Date:  1958-12

4.  [Experimental contribution to the problem of inactivation of bacteriophages by the properdin system].

Authors:  K H HUSMANN
Journal:  Z Hyg Infektionskr       Date:  1959

5.  Properdin System in Infections and in Malignant Blood Dyscrasias.

Authors:  P A Bunn; A L Baltch
Journal:  Trans Am Clin Climatol Assoc       Date:  1959

6.  Properties of the neutralizing factors against T 2 and phi X 174 phages present in normal sera.

Authors:  P Hájek
Journal:  Folia Microbiol (Praha)       Date:  1966       Impact factor: 2.099

7.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. IV. NORMAL ANTIBODY AND EARLY IMMUNE ANTIBODY OF RABBIT ORIGIN: A COMPARISON OF BIOLOGICAL AND PHYSICOCHEMICAL PROPERTIES.

Authors:  S E SVEHAG
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

Review 8.  Neutralization of animal viruses.

Authors:  B Mandel
Journal:  Adv Virus Res       Date:  1978       Impact factor: 9.937

9.  Studies on fractions of methanol extracts of tubercle bacilli. II. Toxic and allergenic properties of fractions employed as antituberculous vaccine.

Authors:  C A WILLIAMS
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.